The Journal of Immunology, Vol 156, Issue 5 1880-1885, Copyright © 1996 by American Association of Immunologists

ARTICLES

Human natural yeast killer toxin-like candidacidal antibodies

L Polonelli, F De Bernadis, S Conti, M Boccanera, W Magliani, M Gerloni, C Cantelli and A Cassone
Institute of Microbiology, University of Parma, Italy.

A murine mAb (mAbKT4, IgG1) that neutralized in vitro the anti-Candida activity of a killer toxic (KT) from the yeast Pichia anomala acted as an idiotypic (Id) vaccine in eliciting anti-Id Abs with toxin-like activity (KT-IdAb) in a rat vaginitis model. In this study, we demonstrate that intravaginal or intragastric inoculations of Candida albicans bearing a receptor for the toxin was able to recall KT-IdAb production in the vagina of the animals primarily immunized with mAbKT4 and also to elicit by themselves an Ab that functionally mimicked the KT (KTAb). Anti-Id-like, KT-like Abs were also consistently found in the vaginal fluid of human vaginitis patients who were infected by Candida but who had never been exposed to the Id vaccine. These Abs were as candidacidal in vitro as those raised in rat vagina by the Id vaccination, and, likewise, their cytocidal effect was totally neutralized by previous reaction with mAbKT4. Importantly, they were also able to confer a significant anticandidal protection in the rat vaginitis model, comparable to that achievable by KT-IdAb passively transferred to naive rats from Id-vaccinated animals. Thus, candidacidal Abs representing the internal image of a yeast KT are part of the Ab repertoire that follows infection or immunization with Candida. It is speculated that the host's immune system response may exploit the KT receptor of microbial pathogens to produce microbicidal Abs, possibly mirroring competition events among microorganisms in natural habitats.

This article has been cited by other articles:

				A. Casadevall and L.-a. Pirofski Antibody-Mediated Protection through Cross-Reactivity Introduces a Fungal Heresy into Immunological Dogma Infect. Immun., November 1, 2007; 75(11): 5074 - 5078. [Full Text] [PDF]

				A. Cassone, F. De Bernardis, and G. Santoni Anticandidal Immunity and Vaginitis: Novel Opportunities for Immune Intervention Infect. Immun., October 1, 2007; 75(10): 4675 - 4686. [Full Text] [PDF]

				D. Selvakumar, M. Miyamoto, Y. Furuichi, and T. Komiyama Inhibition of Fungal {beta}-1,3-Glucan Synthase and Cell Growth by HM-1 Killer Toxin Single-Chain Anti-Idiotypic Antibodies. Antimicrob. Agents Chemother., September 1, 2006; 50(9): 3090 - 3097. [Abstract] [Full Text] [PDF]

				P. L. Fiori, A. Mattana, D. Dessi, S. Conti, W. Magliani, and L. Polonelli In vitro acanthamoebicidal activity of a killer monoclonal antibody and a synthetic peptide J. Antimicrob. Chemother., May 1, 2006; 57(5): 891 - 898. [Abstract] [Full Text] [PDF]

				A. Casadevall and L.-a. Pirofski New Concepts in Antibody-Mediated Immunity Infect. Immun., November 1, 2004; 72(11): 6191 - 6196. [Full Text] [PDF]

				M. D. Moragues, M. J. Omaetxebarria, N. Elguezabal, M. J. Sevilla, S. Conti, L. Polonelli, and J. Ponton A Monoclonal Antibody Directed against a Candida albicans Cell Wall Mannoprotein Exerts Three Anti-C. albicans Activities Infect. Immun., September 1, 2003; 71(9): 5273 - 5279. [Abstract] [Full Text] [PDF]

				E. Cenci, A. Mencacci, A. Spreca, C. Montagnoli, A. Bacci, K. Perruccio, A. Velardi, W. Magliani, S. Conti, L. Polonelli, et al. Protection of Killer Antiidiotypic Antibodies against Early Invasive Aspergillosis in a Murine Model of Allogeneic T-Cell-Depleted Bone Marrow Transplantation Infect. Immun., May 1, 2002; 70(5): 2375 - 2382. [Abstract] [Full Text] [PDF]

				J. P. Martinez, M. L. Gil, J. L. Lopez-Ribot, and W. L. Chaffin Serologic Response to Cell Wall Mannoproteins and Proteins of Candida albicans Clin. Microbiol. Rev., January 1, 1998; 11(1): 121 - 141. [Abstract] [Full Text] [PDF]